• $4.0M
    Market Cap
  • -87.37%
    1-Year Change
  • Biotechnology
    Industry
Annual
Quarterly
12/31/2025
12/31/2024
12/31/2023
Income Statement
Total Operating Revenue
1.0M
+65.49%
607,574
+139.61%
253,573
N/A
Cost of Revenue
781,695
+103.16%
384,765
-18.92%
474,550
N/A
Gross Profit
223,776
+0.43%
222,809
+200.83%
-220,977
N/A
Sales and Marketing Expense
N/A
N/A
N/A
N/A
N/A
N/A
Research and Development Expense
-2.1M
-57.76%
-5.0M
+620.84%
-691,770
N/A
Depreciation and Amortization Expense
43,324
+269.47%
11,726
-44.59%
21,162
N/A
Total Operating Expenses
8.4M
-16.24%
10.0M
+102.92%
4.9M
N/A
Operating Profit
-7.8M
-20.14%
-9.7M
+88.47%
-5.2M
N/A
Interest Income
N/A
N/A
N/A
N/A
N/A
N/A
Interest Expense
N/A
N/A
0
+100.00%
-2.3M
N/A
Interest Income and Expense and Net
0
N/A
0
+100.00%
-2.3M
N/A
Total Nonoperating Income and Expense
390,254
+284.62%
101,464
+222.08%
-83,116
N/A
Income before Taxes
-7.4M
-7.38%
-8.0M
+108.61%
-3.8M
N/A
Income Taxes
0
-100.00%
250
0.00%
250
N/A
Extraordinary Items
N/A
N/A
N/A
N/A
N/A
N/A
Net Income
-7.4M
-7.32%
-7.9M
+111.04%
-3.8M
N/A
Net Income from Continuing Operations Applicable to Common
-7.9M
-6.78%
-8.4M
+3,715.10%
-220,977
N/A
Basic EPS and Net Income
-11.73
-36.77%
-18.55
+1,773.74%
-0.99
N/A
Diluted EPS and Net Income
-11.73
-36.77%
-18.55
+1,773.74%
-0.99
N/A
Basic Weighted Average Shares
670,211
+47.43%
454,582
-88.52%
4.0M
N/A
Diluted Weighted Average Shares
670,211
+47.43%
454,582
-88.52%
4.0M
N/A
Balance Sheet
Cash and Cash Equivalents
1.5M
-9.00%
1.7M
-22.55%
2.1M
N/A
Short-Term Investments
1.2M
-28.22%
1.7M
N/A
N/A
N/A
Cash and Cash Equivalents and Short-Term Investments
2.8M
-18.80%
3.4M
+58.13%
2.1M
N/A
Total Current Assets
4.9M
-9.11%
5.4M
-25.63%
7.2M
N/A
Accumulated Depreciation
190,854
+27.72%
149,433
+0.92%
148,064
N/A
Property and Plant and Equipment and Net
246,365
+64.45%
149,808
+159.36%
57,761
N/A
Total Long-Term Assets
224,361
+0.49%
223,260
-53.82%
483,422
N/A
Total Assets
5.4M
-6.83%
5.8M
-26.01%
7.8M
N/A
Income Taxes Payable
N/A
N/A
N/A
N/A
75,000
N/A
Total Short-Term Debt
8,772
-99.75%
3.5M
-0.35%
3.6M
N/A
Total Current Liabilities
1.8M
+11.20%
1.7M
-41.55%
2.8M
N/A
Total Long-Term Debt
144,003
-4.00%
150,000
-99.35%
23.1M
N/A
Total Long-Term Liabilities
144,003
-2.12%
147,119
-2.08%
150,251
N/A
Total Liabilities
2.0M
+10.11%
1.8M
-39.57%
3.0M
N/A
Retained Earnings
-47.9M
+18.17%
-40.5M
+24.39%
-32.6M
N/A
Total Stockholders Equity
3.5M
-14.18%
4.0M
-17.14%
4.9M
N/A
Total Shares Outstanding
1.4M
-81.55%
7.4M
+26.75%
5.8M
N/A
Cash Flow
Cash from Operating Activities
-6.8M
+21.26%
-5.6M
+24.33%
-4.5M
N/A
Capital Expenditures
139,881
+34.80%
103,773
+80.09%
57,623
N/A
Cash from Investing Activities
254,916
+113.49%
-1.9M
+1,530.12%
-115,888
N/A
Dividends Paid
N/A
N/A
N/A
N/A
N/A
N/A
Cash from Financing Activities
6.4M
-8.73%
7.1M
+8.94%
6.5M
N/A
Financials Ratio
Gross Margin
22.26%
-39.31%
36.67%
N/A
N/A
N/A
Operating Margin
-771.64%
-51.74%
-1,598.97%
N/A
N/A
N/A
Return on Assets
-132.40%
+12.82%
-117.36%
N/A
N/A
N/A
Return on Equity
-196.44%
+10.07%
-178.47%
N/A
N/A
N/A
Revenue Growth
65.49%
-53.09%
139.61%
N/A
N/A
N/A
Current Ratio
2.66
-18.26%
3.25
N/A
N/A
N/A
Cash Ratio
0.82
-18.17%
1.00
N/A
N/A
N/A
Debt-to-Equity Ratio
0.04
-95.18%
0.92
N/A
N/A
N/A
Debt-to-Assets Ratio
0.03
-95.56%
0.64
N/A
N/A
N/A

Earnings & Revenue History

Debt-to-Assets

Cash Flow